Envoy Medical Updates Third Quarter 2026 Earnings Call Time to 8:00 A.M. ET on Thursday, November 5th

Third-quarter results are due before markets open Nov. 5; Envoy Medical's call starts at 8 a.m.

Envoy Medical to Report Third Quarter 2026 Financial Results on Thursday, November 5th

Envoy Medical will host a call at 4:30 p.m. ET on Nov. 5 after releasing its third-quarter results.

IQVIA Holdings (IQV) Surpasses Q3 Earnings and Revenue Estimates

Envoy Medical Announces Reverse Stock Split

Envoy Medical Announces 1-For-10 Reverse Stock Split, Effective Oct. 26

A 1-for-10 split is intended to help Envoy Medical meet Nasdaq’s $1 minimum bid requirement.

Envoy Medical Hits Six-Month Milestone, Marks Halfway Point in Final Stage of Data Collection, and Highlights Differentiated Device Design

Envoy Medical Surpasses 6-Month Follow-Up Visit Milestone For Pivotal Clinical Trial Evaluating Investigational Fully Implanted Acclaim Cochlear Implant; Expects To Submit Final Clinical PMA Module By End Of Q2 2027

Envoy Medical Submits Second Module of Modular Premarket Approval Application to FDA for Breakthrough Designated Acclaim(R) Cochlear Implant

Envoy Medical Submits Second FDA Module Of Its PMA Application For The Acclaim Cochlear Implant; Targets Final Clinical Submission In Q2 2027

Envoy Medical Announces Delaware Chancery Court Dismissal With Prejudice Of Atlas Merchant Capital Spac Fund I's Claim That It Was Not Allowed To Redeem Shares

Lake Street Initiates Coverage On Envoy Medical with Buy Rating, Announces Price Target of $2.5

Envoy Medical Announces New Patents, Further Expanding Global Patent Portfolio